The study supports prior research that found the same thing.

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.